Skip to main content
Top
Published in: Diabetologia 3/2021

01-03-2021 | Obesity | Article

Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study: newborn anthropometrics and childhood glucose metabolism

Authors: Monica E. Bianco, Alan Kuang, Jami L. Josefson, Patrick M. Catalano, Alan R. Dyer, Lynn P. Lowe, Boyd E. Metzger, Denise M. Scholtens, William L. Lowe Jr., on behalf of the HAPO Follow-Up Study Cooperative Research Group

Published in: Diabetologia | Issue 3/2021

Login to get access

Abstract

Aims/hypothesis

We aimed to examine associations of newborn anthropometric measures with childhood glucose metabolism with the hypothesis that greater newborn birthweight, adiposity and cord C-peptide are associated with higher childhood glucose levels and lower insulin sensitivity.

Methods

Data from the international, multi-ethnic, population-based Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study and the HAPO Follow-Up Study were used. The analytic cohort included 4155 children (mean age [SD], 11.4 [1.2] years; 51.0% male). Multiple linear regression was used to examine associations of primary predictors, birthweight, newborn sum of skinfolds (SSF) and cord C-peptide, from HAPO with continuous child glucose outcomes from the HAPO Follow-Up Study.

Results

In an initial model that included family history of diabetes and maternal BMI during pregnancy, birthweight and SSF demonstrated a significant, inverse association with 30 min and 1 h plasma glucose levels. In the primary model, which included further adjustment for maternal sum of glucose z scores from an oral glucose tolerance test during pregnancy, the associations were strengthened, and birthweight and SSF were inversely associated with fasting, 30 min, 1 h and 2 h plasma glucose levels. Birthweight and SSF were also associated with higher insulin sensitivity (Matsuda index) (β = 1.388; 95% CI 0.870, 1.906; p < 0.001; β = 0.792; 95% CI 0.340, 1.244; p < 0.001, for birthweight and SSF higher by 1 SD, respectively) in the primary model, while SSF, but not birthweight, was positively associated with the disposition index, a measure of beta cell compensation for insulin resistance (β = 0.034; 95% CI 0.012, 0.056; p = 0.002). Cord C-peptide levels were inversely associated with Matsuda index (β = −0.746; 95% CI −1.188, −0.304; p < 0.001 for cord C-peptide higher by 1 SD) in the primary model.

Conclusions/interpretation

This study demonstrates that higher birthweight and SSF are associated with greater childhood insulin sensitivity and lower glucose levels following a glucose load, associations that were further strengthened after adjustment for maternal glucose levels during pregnancy.
Appendix
Available only for authorised users
Literature
29.
go back to reference R Core Team (2016) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Core Team (2016) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
38.
go back to reference Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S (2019) Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care 42:265–272. https://doi.org/10.2337/dc18-1178CrossRefPubMed Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S (2019) Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care 42:265–272. https://​doi.​org/​10.​2337/​dc18-1178CrossRefPubMed
Metadata
Title
Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study: newborn anthropometrics and childhood glucose metabolism
Authors
Monica E. Bianco
Alan Kuang
Jami L. Josefson
Patrick M. Catalano
Alan R. Dyer
Lynn P. Lowe
Boyd E. Metzger
Denise M. Scholtens
William L. Lowe Jr.
on behalf of the HAPO Follow-Up Study Cooperative Research Group
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 3/2021
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-020-05331-0

Other articles of this Issue 3/2021

Diabetologia 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.